LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Search

Accuray Inc

Fermé

SecteurSoins de santé

0.52

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.5

Max

0.52

Chiffres clés

By Trading Economics

Revenu

7.9M

-14M

Ventes

8.3M

102M

BPA

-0.108

Marge bénéficiaire

-13.468

Employés

990

EBITDA

7M

-3.3M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+263.64% upside

Dividendes

By Dow Jones

Prochains Résultats

29 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-25M

66M

Ouverture précédente

0.52

Clôture précédente

0.52

Sentiment de l'Actualité

By Acuity

20%

80%

37 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Accuray Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 mars 2026, 23:39 UTC

Actions en Tendance

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mars 2026, 23:20 UTC

Résultats

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mars 2026, 21:43 UTC

Résultats

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mars 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mars 2026, 23:33 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mars 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mars 2026, 22:30 UTC

Résultats

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mars 2026, 22:30 UTC

Résultats

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mars 2026, 22:30 UTC

Résultats

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mars 2026, 22:13 UTC

Résultats

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mars 2026, 22:13 UTC

Résultats

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mars 2026, 22:13 UTC

Résultats

Vermilion Energy 4Q EPS C$2.86 >VET

4 mars 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mars 2026, 21:53 UTC

Résultats

Lithium Americas 4Q Rev $66.8M >LAC

4 mars 2026, 21:53 UTC

Résultats

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mars 2026, 21:52 UTC

Résultats

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mars 2026, 21:50 UTC

Résultats

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mars 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 mars 2026, 21:48 UTC

Résultats

Webull 4Q Rev $165.2M >BULL

4 mars 2026, 21:48 UTC

Résultats

Webull 4Q EPS 1c >BULL

4 mars 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 mars 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mars 2026, 21:40 UTC

Résultats

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mars 2026, 21:36 UTC

Principaux Événements d'Actualité

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mars 2026, 21:27 UTC

Résultats

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mars 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mars 2026, 21:16 UTC

Résultats

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mars 2026, 21:15 UTC

Résultats

Broadcom 1Q EPS $1.50 >AVGO

4 mars 2026, 21:15 UTC

Résultats

Broadcom 1Q Net $7.35B >AVGO

4 mars 2026, 21:15 UTC

Résultats

Broadcom 1Q Rev $19.31B >AVGO

Comparaison

Variation de prix

Accuray Inc prévision

Objectif de Prix

By TipRanks

263.64% hausse

Prévisions sur 12 Mois

Moyen 2 USD  263.64%

Haut 2 USD

Bas 2 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

1 ratings

1

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

1.28 / 1.61Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

37 / 351Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat